Glutathione-sensitive nanoparticles enhance the combined therapeutic effect of checkpoint kinase 1 inhibitor and cisplatin in prostate cancer

Prostate cancer (PCa) is the second most common malignant tumor among males. Traditional treatments for PCa, which include surgery and endocrine therapy, have shown limited success, and more effective therapies are needed. Cisplatin (DDP) is an approved chemotherapeutic drug that causes DNA damage i...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Shirong, Zhang, Xinyu, Huang, Hao, Cheng, Bisheng, Xiong, Zhi, Du, Tao, Wu, Jun, Huang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIP Publishing LLC 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686925/
https://www.ncbi.nlm.nih.gov/pubmed/36440378
http://dx.doi.org/10.1063/5.0126095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686925/
https://www.ncbi.nlm.nih.gov/pubmed/36440378
http://dx.doi.org/10.1063/5.0126095

Ejemplares similares